![]() |
Lillian Lian
Ms. Lian is an associate in Davis Polk’s Corporate Department, resident in Hong Kong. Her practice areas include capital markets, mergers and acquisitions and financing. She is dual-qualified in Hong Kong and the PRC. |
Work Highlights
Capital Markets
- Bairong Inc's $454.5 million Hong Kong IPO and global offering
- New Horizon Health's $263 million Hong Kong IPO and global offering
- RemeGen's $514.3 million Hong Kong IPO and global offering
- JW Therapeutics' $300 million Hong Kong IPO and global offering
- Ocumension Therapeutics' $200.4 million Hong Kong IPO and global offering
- Shenzhen Hepalink Pharmaceutical's $523 million Hong Kong IPO and global offering
- NetEase's $3.1 billion Hong Kong secondary listing
- Legend Biotech's $487 million SEC-registered U.S. IPO on Nasdaq
- Haitong UniTrust International Leasing's $297.7 million Hong Kong IPO and global offering
- Meituan Dianping's $4.22 billion Hong Kong IPO and global offering
- Ping An Healthcare and Technology's $1.12 billion Hong Kong IPO and global offering
- CSC Financial’s $915 million Hong Kong IPO and global offering
- Orient Securities Company’s $876 million Hong Kong IPO and global offering
- China Development Bank Financial Leasing's $776 million Hong Kong IPO and global offering
- CAR Inc.'s $468 million Hong Kong IPO and global offering
- BAIOO Family Interactive's $196 million Hong Kong IPO and global offering
- China Galaxy Securities' $1.1 billion Hong Kong IPO and global offering
- China Pacific Insurance's $3.1 billion Hong Kong IPO and global offering*
- The underwriters on the $1.7 billion Hong Kong IPO and global offering of Fosun International*
- Chinalco Mining Corporation International's $438 million Hong Kong IPO and global offering*
- China Investment Corporation's HK$3.12 billion block trade of shares
- China Oilfield Services' $759 million placement of H shares
- China National Building Material Company's HK$3.8 billion secondary placing of shares*
- China Power New Energy Development Company's HK$2.1 billion placement of new shares to China Three Gorges Corporation*
M&A
- CNOOC’s $17.1 billion acquisition of Nexen Inc.
- CAR Inc. on the $125 million subscription of Series A preferred shares in UCAR Technology Inc.
- Koninklijke Philips Electronics NV‘s sale of its color TV business in China to TPV Technology under a share sale and purchase agreement*
- China Power International Development’s $650 million acquisition of Wu Ling Power*
- One of the largest gypsum board producers in the PRC on its proposed RMB1.2 billion acquisition of 40% of the equity interest in a cement company in China*
Financing
- CAR Inc.'s $300 million and $500 million notes offerings
- COFCO Land's $800 million senior notes offering and listing on the HKEx
- China Power New Energy Development Company's RMB800 million private placement of RMB-denominated guaranteed bonds to the trustees of China Life Insurance (Overseas) Company*
- China Power New Energy Development Company's RMB 500 million RMB-denominated guaranteed bonds offering*
- The financial adviser on the HK$800 million syndicated term loan facility to China Resources Gas Group*
compliance
- Several companies listed on the Hong Kong Stock Exchange on the post-listing compliance and corporate matters
_____________________
* Selected representations before joining Davis Polk
Professional History
- Davis Polk since 2012
- Slaughter and May, 2008-2012
- Lord Chancellor’s Training Scheme for Young Chinese Lawyers, 2004-2005
- Fujian Howsen, PRC Law Firm, 2001-2003